Three-Statement Breakdown
LITTLE CHANGED
Revenue was little changed at $138.9B year over year, and carried a 11.6% net margin.
REVENUE
+1.4%
138,895
GROSS PROFIT
—
—
NET INCOME
-11.1%
16,172
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-03 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 134,237 | 134,788 | 135,292 | 137,000 | 137,491 | 138,191 | 139,146 | 138,895 | -0.2% | +1.4% | |
| SG&A | (34,864) | (34,113) | (33,844) | (33,632) | (31,678) | (33,818) | (33,577) | (34,747) | +3.5% | +3.3% | |
| Operating income | 21,865 | 28,686 | 29,143 | 29,497 | 31,676 | 29,259 | 29,523 | 28,530 | -3.4% | -3.3% | |
| Interest expense | (6,604) | (6,649) | (6,646) | (6,587) | (6,579) | (6,694) | (7,002) | (7,348) | +4.9% | +11.6% | |
| Income tax | (4,332) | (5,030) | (5,167) | (5,323) | (5,903) | (5,064) | (5,212) | (5,049) | -3.1% | -5.1% | |
| Net income | 9,796 | 17,506 | 17,783 | 18,193 | 19,837 | 17,174 | 17,340 | 16,172 | -6.7% | -11.1% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-31 ↗